These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25056532)

  • 21. The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson's disease: A randomized, double-blind, placebo-controlled trial.
    Taghizadeh M; Tamtaji OR; Dadgostar E; Daneshvar Kakhaki R; Bahmani F; Abolhassani J; Aarabi MH; Kouchaki E; Memarzadeh MR; Asemi Z
    Neurochem Int; 2017 Sep; 108():183-189. PubMed ID: 28342967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective role of vitamin E on the oxidative stress in Hansen's disease (Leprosy) patients.
    Vijayaraghavan R; Suribabu CS; Sekar B; Oommen PK; Kavithalakshmi SN; Madhusudhanan N; Panneerselvam C
    Eur J Clin Nutr; 2005 Oct; 59(10):1121-8. PubMed ID: 16015260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone in the treatment of schizophrenia.
    Marder SR; Meibach RC
    Am J Psychiatry; 1994 Jun; 151(6):825-35. PubMed ID: 7514366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An increase in plasma brain derived neurotrophic factor levels is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: secondary outcome analysis of the OFFER randomized clinical trial.
    Pawełczyk T; Grancow-Grabka M; Trafalska E; Szemraj J; Żurner N; Pawełczyk A
    Psychopharmacology (Berl); 2019 Sep; 236(9):2811-2822. PubMed ID: 31098654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia.
    Pawełczyk T; Grancow-Grabka M; Kotlicka-Antczak M; Trafalska E; Pawełczyk A
    J Psychiatr Res; 2016 Feb; 73():34-44. PubMed ID: 26679763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amoxapine as an antipsychotic: comparative study versus haloperidol.
    Chaudhry IB; Husain N; Khan S; Badshah S; Deakin B; Kapur S
    J Clin Psychopharmacol; 2007 Dec; 27(6):575-81. PubMed ID: 18004123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
    de Haan L; van Bruggen M; Lavalaye J; Booij J; Dingemans PM; Linszen D
    Am J Psychiatry; 2003 Feb; 160(2):303-9. PubMed ID: 12562577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects.
    Remans PH; Sont JK; Wagenaar LW; Wouters-Wesseling W; Zuijderduin WM; Jongma A; Breedveld FC; Van Laar JM
    Eur J Clin Nutr; 2004 Jun; 58(6):839-45. PubMed ID: 15164103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ω-3 fatty acids as an adjuvant therapy ameliorates methotrexate-induced hepatotoxicity in children and adolescents with acute lymphoblastic leukemia: A randomized placebo-controlled study.
    Elbarbary NS; Ismail EA; Farahat RK; El-Hamamsy M
    Nutrition; 2016 Jan; 32(1):41-7. PubMed ID: 26421385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ageing improves the antioxidant response against postoperative atrial fibrillation: a randomized controlled trial.
    Rodrigo R; Gutiérrez R; Fernández R; Guzmán P
    Interact Cardiovasc Thorac Surg; 2012 Aug; 15(2):209-14. PubMed ID: 22561296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial.
    Passerieux E; Hayot M; Jaussent A; Carnac G; Gouzi F; Pillard F; Picot MC; Böcker K; Hugon G; Pincemail J; Defraigne JO; Verrips T; Mercier J; Laoudj-Chenivesse D
    Free Radic Biol Med; 2015 Apr; 81():158-69. PubMed ID: 25246239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longterm maintenance therapy with depot haloperidol in schizophrenia.
    Zbytovský J
    Homeost Health Dis; 1991; 33(5-6):287. PubMed ID: 18265499
    [No Abstract]   [Full Text] [Related]  

  • 35. Vitamin C and E supplementation prevents some of the cellular adaptations to endurance-training in humans.
    Morrison D; Hughes J; Della Gatta PA; Mason S; Lamon S; Russell AP; Wadley GD
    Free Radic Biol Med; 2015 Dec; 89():852-62. PubMed ID: 26482865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Citrome L; Jaffe A; Levine J
    Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low- and standard-dose depot haloperidol combined with targeted oral neuroleptics.
    Huttunen MO; Tuhkanen H; Haavisto E; Nyholm R; Pitkänen M; Raitasuo V; Romanov M
    Psychiatr Serv; 1996 Jan; 47(1):83-5. PubMed ID: 8925352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of essential fatty acid supplementation in dogs with idiopathic epilepsy: a clinical trial.
    Matthews H; Granger N; Wood J; Skelly B
    Vet J; 2012 Mar; 191(3):396-8. PubMed ID: 21641244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.
    Wright P; Birkett M; David SR; Meehan K; Ferchland I; Alaka KJ; Saunders JC; Krueger J; Bradley P; San L; Bernardo M; Reinstein M; Breier A
    Am J Psychiatry; 2001 Jul; 158(7):1149-51. PubMed ID: 11431240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn's disease in remission: effects on antioxidant status and fatty acid profile.
    Geerling BJ; Badart-Smook A; van Deursen C; van Houwelingen AC; Russel MG; Stockbrügger RW; Brummer RJ
    Inflamm Bowel Dis; 2000 May; 6(2):77-84. PubMed ID: 10833065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.